These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 28316761)

  • 1. Polyethylene Glycol and Lactulose versus Lactulose Alone in the Treatment of Hepatic Encephalopathy in Patients with Cirrhosis: A Non-Inferiority Randomized Controlled Trial.
    Naderian M; Akbari H; Saeedi M; Sohrabpour AA
    Middle East J Dig Dis; 2017 Jan; 9(1):12-19. PubMed ID: 28316761
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lactulose vs polyethylene glycol 3350--electrolyte solution for treatment of overt hepatic encephalopathy: the HELP randomized clinical trial.
    Rahimi RS; Singal AG; Cuthbert JA; Rockey DC
    JAMA Intern Med; 2014 Nov; 174(11):1727-33. PubMed ID: 25243839
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacotherapies that specifically target ammonia for the prevention and treatment of hepatic encephalopathy in adults with cirrhosis.
    Zacharias HD; Zacharias AP; Gluud LL; Morgan MY
    Cochrane Database Syst Rev; 2019 Jun; 6(6):CD012334. PubMed ID: 31204790
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combined PEG3350 Plus Lactulose Results in Early Resolution of Hepatic Encephalopathy and Improved 28-Day Survival in Acute-on-Chronic Liver Failure.
    Ahmed S; Premkumar M; Dhiman RK; Kulkarni AV; Imran R; Duseja A; Kaur P; Taneja S; Singh V; Mishra S; Roy A; Mehtani R
    J Clin Gastroenterol; 2022 Jan; 56(1):e11-e19. PubMed ID: 33060437
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Randomized controlled trial of polyethylene glycol versus lactulose for the treatment of overt hepatic encephalopathy.
    Shehata HH; Elfert AA; Abdin AA; Soliman SM; Elkhouly RA; Hawash NI; Soliman HH
    Eur J Gastroenterol Hepatol; 2018 Dec; 30(12):1476-1481. PubMed ID: 30234645
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Polyethylene glycol versus lactulose in the treatment of hepatic encephalopathy: a systematic review and meta-analysis.
    Hoilat GJ; Ayas MF; Hoilat JN; Abu-Zaid A; Durer C; Durer S; Adhami T; John S
    BMJ Open Gastroenterol; 2021 May; 8(1):. PubMed ID: 34006606
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative Effectiveness and Safety of Polyethylene Glycol Electrolyte Solution Versus Lactulose for Treatment of Hepatic Encephalopathy: A Systematic Review and Meta-analysis.
    Li M; Zhang Z; Chen Q; Zhou X; Shui D; Huang J
    J Clin Gastroenterol; 2022 Jan; 56(1):41-48. PubMed ID: 34739404
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Orthograde whole gut irrigation with mannite versus paromomycine + lactulose as prophylaxis of hepatic encephalopathy in patients with cirrhosis and upper gastrointestinal bleeding: results of a controlled randomized trial.
    Tromm A; Griga T; Greving I; Hilden H; Hüppe D; Schwegler U; Micklefield GH; May B
    Hepatogastroenterology; 2000; 47(32):473-7. PubMed ID: 10791216
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Randomized controlled trial comparing lactulose plus albumin versus lactulose alone for treatment of hepatic encephalopathy.
    Sharma BC; Singh J; Srivastava S; Sangam A; Mantri AK; Trehanpati N; Sarin SK
    J Gastroenterol Hepatol; 2017 Jun; 32(6):1234-1239. PubMed ID: 27885712
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A randomized, double-blind, controlled trial comparing rifaximin plus lactulose with lactulose alone in treatment of overt hepatic encephalopathy.
    Sharma BC; Sharma P; Lunia MK; Srivastava S; Goyal R; Sarin SK
    Am J Gastroenterol; 2013 Sep; 108(9):1458-63. PubMed ID: 23877348
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Non-absorbable disaccharides versus placebo/no intervention and lactulose versus lactitol for the prevention and treatment of hepatic encephalopathy in people with cirrhosis.
    Gluud LL; Vilstrup H; Morgan MY
    Cochrane Database Syst Rev; 2016 May; 2016(5):CD003044. PubMed ID: 27153247
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cochrane Review: Osmotic and stimulant laxatives for the management of childhood constipation (Review).
    Gordon M; Naidoo K; Akobeng AK; Thomas AG
    Evid Based Child Health; 2013 Jan; 8(1):57-109. PubMed ID: 23878124
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Non-absorbable disaccharides versus placebo/no intervention and lactulose versus lactitol for the prevention and treatment of hepatic encephalopathy in people with cirrhosis.
    Gluud LL; Vilstrup H; Morgan MY
    Cochrane Database Syst Rev; 2016 Apr; 4():CD003044. PubMed ID: 27089005
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of Rifaximin Plus Lactulose with the Lactulose Alone for the Treatment of Hepatic Encephalopathy.
    Ahire K; Sonawale A
    J Assoc Physicians India; 2017 Aug; 65(8):42-46. PubMed ID: 28799305
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Laxation of critically ill patients with lactulose or polyethylene glycol: a two-center randomized, double-blind, placebo-controlled trial.
    van der Spoel JI; Oudemans-van Straaten HM; Kuiper MA; van Roon EN; Zandstra DF; van der Voort PH
    Crit Care Med; 2007 Dec; 35(12):2726-31. PubMed ID: 17893628
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Probiotics for patients with hepatic encephalopathy.
    McGee RG; Bakens A; Wiley K; Riordan SM; Webster AC
    Cochrane Database Syst Rev; 2011 Nov; (11):CD008716. PubMed ID: 22071855
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Outcomes of lactulose plus branched-chain amino acid infusion and lactulose alone for hepatic encephalopathy: A retrospective cohort study using a national inpatient database.
    Okada A; Yamana H; Yamaguchi S; Ikeda Kurakawa K; Matsui H; Fushimi K; Nangaku M; Kadowaki T; Yasunaga H
    Hepatol Res; 2020 Jun; 50(6):693-703. PubMed ID: 31943593
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Zinc supplementation in patients with cirrhosis and hepatic encephalopathy: a systematic review and meta-analysis.
    Shen YC; Chang YH; Fang CJ; Lin YS
    Nutr J; 2019 Jul; 18(1):34. PubMed ID: 31279342
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of oral L-ornithine-L-aspartate in cirrhotic patients with hyperammonemic hepatic encephalopathy. Results of a randomized, lactulose-controlled study.
    Poo JL; Góngora J; Sánchez-Avila F; Aguilar-Castillo S; García-Ramos G; Fernández-Zertuche M; Rodríguez-Fragoso L; Uribe M
    Ann Hepatol; 2006; 5(4):281-8. PubMed ID: 17151582
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Current Hepatic Encephalopathy Pipeline.
    Ryu AJ; Rahimi RS; Leise MD
    J Clin Exp Hepatol; 2020; 10(4):377-385. PubMed ID: 32655239
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.